The aim of this study is to investigate potential health benefits of the experimental formula. The main objective is whether the experimental formula elevates the relative abundance of Bifidobacterium in stool samples after 10 weeks, as compared a standard formula, aka control formula. In addition other markers of gut health, such as stool characteristics, and gut health symptoms will be monitored
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
120
ad-libitum consumption of infant formula
ad-libitum consumption
Second SAGBAL Sheinovo AD
Sofia, Bulgaria
RECRUITINGBifidobacterium
Relative abundance of bifidobacterium from stool samples
Time frame: From enrollment to the end of treatment at 10 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.